THERAPEUTIC POTENTIAL OF HPMPC AS AN ANTIVIRAL DRUG

[1] COMPARATIVE ACTIVITY OF SELECTED ANTIVIRAL COMPOUNDS AGAINST CLINICAL ISOLATES OF HUMAN CYTOMEGALOVIRUS [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (12) : 1026 - 1033

[2] COMPARATIVE ACTIVITY OF VARIOUS COMPOUNDS AGAINST CLINICAL STRAINS OF HERPES-SIMPLEX VIRUS [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (02) : 143 - 151

[3] INHIBITION OF AFRICAN SWINE FEVER VIRUS-DNA SYNTHESIS BY (S)-9-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)ADENINE [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (01) : 27 - 32

[4] INVITRO ACTIVITY OF (S)-9-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)-ADENINE AGAINST NEWLY ISOLATED CLINICAL VARICELLA-ZOSTER VIRUS-STRAINS [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (02) : 158 - 160

[5] SELECTIVE INHIBITORY EFFECT OF (S)-9-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)ADENINE AND 2'-NOR-CYCLIC GMP ON ADENOVIRUS REPLICATION INVITRO [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) : 337 - 339

[6] A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) : 8769 - 8773

[7] BIRON KK, 1991, TRANSPLANT P, V23, P162

[8] EVALUATION OF HPMPC THERAPY FOR PRIMARY AND RECURRENT GENITAL HERPES IN MICE AND GUINEA-PIGS [J]. ANTIVIRAL RESEARCH, 1993, 21 (01) : 59 - 72

[9] SYNTHESIS AND ANTIVIRAL ACTIVITY OF THE NUCLEOTIDE ANALOG (S)-1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (07) : 1457 - 1463

[10] BRONSON JJ, 1989, ACS SYM SER, V401, P88

[1] COMPARATIVE ACTIVITY OF SELECTED ANTIVIRAL COMPOUNDS AGAINST CLINICAL ISOLATES OF HUMAN CYTOMEGALOVIRUS [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (12) : 1026 - 1033

[2] COMPARATIVE ACTIVITY OF VARIOUS COMPOUNDS AGAINST CLINICAL STRAINS OF HERPES-SIMPLEX VIRUS [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (02) : 143 - 151

[3] INHIBITION OF AFRICAN SWINE FEVER VIRUS-DNA SYNTHESIS BY (S)-9-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)ADENINE [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (01) : 27 - 32

[4] INVITRO ACTIVITY OF (S)-9-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)-ADENINE AGAINST NEWLY ISOLATED CLINICAL VARICELLA-ZOSTER VIRUS-STRAINS [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (02) : 158 - 160

[5] SELECTIVE INHIBITORY EFFECT OF (S)-9-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)ADENINE AND 2'-NOR-CYCLIC GMP ON ADENOVIRUS REPLICATION INVITRO [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (02) : 337 - 339

[6] A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) : 8769 - 8773

[7] BIRON KK, 1991, TRANSPLANT P, V23, P162

[8] EVALUATION OF HPMPC THERAPY FOR PRIMARY AND RECURRENT GENITAL HERPES IN MICE AND GUINEA-PIGS [J]. ANTIVIRAL RESEARCH, 1993, 21 (01) : 59 - 72

[9] SYNTHESIS AND ANTIVIRAL ACTIVITY OF THE NUCLEOTIDE ANALOG (S)-1-[3-HYDROXY-2-(PHOSPHONYLMETHOXY)PROPYL]CYTOSINE [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (07) : 1457 - 1463

[10] BRONSON JJ, 1989, ACS SYM SER, V401, P88